Diphenhydramine

Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19

Retrieved on: 
Friday, March 22, 2024
Diphenhydramine, Anaphylaxis, Hook effect, Pre-exposure prophylaxis, Half-life, Risk, Bone marrow, COVID-19, Patient, Metoprolol, Adrenaline, Epitope, DSM-IV codes, SARS-CoV-2, Death, Adolescence, Bank statement, Post-exposure prophylaxis, Clinical trial, CDC, Antibody, Vaccination, Safety, Immunodeficiency, Vaccine, FDA, Food, Medicine

Recipients should not be currently infected with or have had a known recent exposure to an individual infected with SARS-CoV-2.

Key Points: 
  • Recipients should not be currently infected with or have had a known recent exposure to an individual infected with SARS-CoV-2.
  • “The PEMGARDA EUA marks a transformational moment for Invivyd and for the many moderately to severely immunocompromised people who are vulnerable to COVID-19 disease in the U.S.
  • It was developed using INVYMAB™, the company’s platform approach which combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering.
  • The severity of the reactions was generally mild (17/27) or moderate (8/27), but two reactions were life-threatening.

Keystone Lab Announces Addition of Tianeptine to Testing Menu

Retrieved on: 
Tuesday, February 13, 2024
Clozapine, Anxiety, Opioid use disorder, Modafinil, Diphenhydramine, FDA, Pain, MC5, Aripiprazole, Food and Drug Administration, Forensic toxicology, Loperamide, Death, Keystone, Neptune, Abdominal pain, Patient, CLIA, Urine, Tianeptine, Depression

ASHEVILLE, N.C., Feb. 13, 2024 /PRNewswire/ -- Keystone Lab , a dual-CAP accredited and CLIA certified lab based in Asheville, NC, has officially added tianeptine to its in-house urine clinical toxicology menu.

Key Points: 
  • ASHEVILLE, N.C., Feb. 13, 2024 /PRNewswire/ -- Keystone Lab , a dual-CAP accredited and CLIA certified lab based in Asheville, NC, has officially added tianeptine to its in-house urine clinical toxicology menu.
  • Keystone provides clinical and forensic toxicology testing services throughout the southeastern U.S. and is one of few labs in the southeast to offer testing for tianeptine.
  • In addition to tianeptine and its metabolite, tianeptine metabolite MC5, Keystone has also added clozapine, N-desmethylclozapine, aripiprazole, aripiprazole metabolite OPC-3373, modafinil, diphenhydramine, loperamide, and 7OH-mitragynine to its in-house menu.
  • "By adding tianeptine testing in-house, Keystone is able to listen to its clients and provide the best service possible to their patients."

Genexa Launches Clean Line of Kids’ Medicine in Whole Foods Market

Retrieved on: 
Tuesday, December 12, 2023
Retail, Other Health, Organic Food, General Health, Women, Teens, Parenting, Other Retail, Men, Children, Supermarket, Family, Vitamins, Supplements, Food, Beverage, Consumer, Health, Holiday, Whole Foods Market, Tablet, Multimedia, FDA, Heartburn, Calcium carbonate, Donnie Vie, Hydrogen chloride, Paracetamol, Parent, Agave, OTC, Diphenhydramine, Patent, Dietary supplement, Fever

As the impending cold and flu season draws near, Genexa proudly announces the debut of its highly acclaimed clean, and effective, line of over-the-counter (OTC) children’s medicines at Whole Foods Market stores.

Key Points: 
  • As the impending cold and flu season draws near, Genexa proudly announces the debut of its highly acclaimed clean, and effective, line of over-the-counter (OTC) children’s medicines at Whole Foods Market stores.
  • And, we are also so proud to have our OTC products on shelf at Whole Foods,” said Genexa CEO David Johnson.
  • Genexa Kids’ Pain & Fever is an oral suspension for kids ages 2-11.
  • In addition to the children’s line, Whole Foods Market also carries Genexa’s adult pain relievers Acetaminophen Extra Strength and Acetaminophen PM.

DELTA BrainLuxury™ Wins Best Sleep Support Supplement Product

Retrieved on: 
Monday, February 13, 2023
GAMMA, Glycine, DELTA, Diphenhydramine, Sleep, Melatonin, Serotonin, Vitamin, Tryptophan, Pharmaceutical industry

NEW YORK , Feb. 13, 2023 /PRNewswire/ -- DELTA BrainLuxury™, has been recognized by Nootropics Planet as the Best Sleep Support Supplement Product in the market for sleep supplements and sleep aids. Offered by the award-winning company BRAINLUXURY™, it may provide a more natural alternative to sleep supplements containing melatonin and over-the-counter sleep aids containing diphenhydramine, delivering a unique formulation superior to those of its competitors, many of which are larger, better-known brands fighting for an increased revenue share in this very competitive and fast-growing market segment. DELTA BrainLuxury™ is the best product in virtually every important aspect, and the company is on a very impressive trajectory. [See full release]

Key Points: 
  • Its premier product, DELTA BrainLuxury™, is worth serious consideration as a safer, more effective alternative to other supplements and over-the-counter sleep aids.
  • NEW YORK , Feb. 13, 2023 /PRNewswire/ -- DELTA BrainLuxury™, has been recognized by Nootropics Planet as the Best Sleep Support Supplement Product in the market for sleep supplements and sleep aids.
  • DELTA BrainLuxury™ is the best product in virtually every important aspect, and the company is on a very impressive trajectory.
  • Named after delta brain waves that are present during deep sleep, DELTA BrainLuxury™ may help customers to fall asleep faster, sleep more deeply, and wake up feeling better-rested and refreshed due to its support of the body's natural functioning.

Jessica Biel's KinderFarms Launches Clean Medicine Brand KinderMed

Retrieved on: 
Tuesday, November 15, 2022
Family, Pediatrics, Infant, Amazon, Phenylephrine, Diphenhydramine, GMO, CVS, Congestion, Agave syrup, Parent, Target Corporation, Kinder, CEO, FD, Rite Aid, Sodium benzoate, Walmart, OTC, Paraben, Toy, Soft drink, Distribution (marketing), Guaifenesin, Cough, Facebook, Walgreens

NEW YORK, Nov. 15, 2022 /PRNewswire/ -- KinderFarms, the Kinder Farmaceutical Company, is proud to announce the launch of KinderMed – a line of clean children's medicines, made with clinically proven active ingredients, but clean, Kinder inactive ingredients.

Key Points: 
  • NEW YORK, Nov. 15, 2022 /PRNewswire/ --KinderFarms, the Kinder Farmaceutical Company, is proud to announce the launch of KinderMed a line of clean children's medicines, made with clinically proven active ingredients, but clean, Kinder inactive ingredients.
  • KinderFarms was co-founded by parents Jessica Biel and Jeremy Adams when they couldn't find children's health products that were both effective and aligned with their values.
  • So they set out to fill the gap in the pharmacy aisle for clean, effective options for families who share their values.
  • "We created KinderMed because we believe that no parent should ever have to choose between non-toxic and effective when it comes to their child's healthcare products."

Gopuff Launches Private Label Health and Wellness Brand, Goodnow

Retrieved on: 
Monday, October 3, 2022
Alternative Medicine, Other Retail, General Health, Health, Convenience Store, Online Retail, Discount, Variety, Retail, Paracetamol, OTC, Food, Private label, UTI, Diphenhydramine, GMP, Cetirizine, Loratadine, Sleep, Health, Twitter, Multimedia, Instagram, Medicine, Allergy, Ibuprofen, Naproxen, IOS, Feedback, Antacid, Beauty, BV, Commerce, Bandage, Android, Online shopping, Gopuff

Gopuff , the go-to platform for immediate delivery of consumers everyday needs, today announced the launch of Goodnow, a private label line of health and wellness products.

Key Points: 
  • Gopuff , the go-to platform for immediate delivery of consumers everyday needs, today announced the launch of Goodnow, a private label line of health and wellness products.
  • View the full release here: https://www.businesswire.com/news/home/20221003005209/en/
    Gopuff announced the launch of Goodnow, a private label line of health and wellness products designed to help customers feel better faster - for less.
  • (Photo: Business Wire)
    Health and wellness - an $80+ billion market in the U.S. - has been one of Gopuffs fastest-growing categories, said Jessica Glendenning, Director of Private Label at Gopuff.
  • As consumers become increasingly interested in private label products, Gopuff is uniquely positioned to develop new brands curated specifically for our customers.

Genexa® Launches the First Ever Clean Acetaminophen Pain Relief Products for Adults

Retrieved on: 
Wednesday, April 27, 2022
Women, Seniors, Pharmaceutical, Men, General Health, Health, Consumer, Other Health, CEO, Diphenhydramine, Pain, Medicine, Analgesic, Pains, Extra Strength, FD, Propylene glycol, Fever, Fast Company, Lactose, OTC, Sorbitol, Patient, Arthritis, Stock, Founder, Paracetamol, FD&C, Talc, Allergen, Microdeletion syndrome, Toothache, Pain scale, Headache, Walmart, Worldwide, No, Hydrogen chloride, Amazon, FDA, Multimedia, Industry, Digestion, Allergy, CVS, Dietary supplement, Pharmaceutical industry

Genexa Acetaminophen Extra Strength has 500mg of the pain reliever acetaminophen, the same dosage found in Extra Strength Tylenol, and Genexa Acetaminophen PM has 500mg of the pain reliever acetaminophen and 25 mg of diphenhydramine HCl, the same dosage found in Tylenol PM.

Key Points: 
  • Genexa Acetaminophen Extra Strength has 500mg of the pain reliever acetaminophen, the same dosage found in Extra Strength Tylenol, and Genexa Acetaminophen PM has 500mg of the pain reliever acetaminophen and 25 mg of diphenhydramine HCl, the same dosage found in Tylenol PM.
  • Made with clean inactive ingredients, Genexa Acetaminophen Extra Strength is used to temporarily relieve minor aches and pains due to the common cold, headache, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps and temporarily reduce fever.
  • Genexa Acetaminophen PM provides temporary relief of occasional headaches and minor aches and pains with accompanying sleeplessness.
  • With a shared belief in making clean medicine accessible to all, Walmart is the exclusive mass retailer for Genexas acetaminophen products.

 ZzzQuil Launches ‘Better Sleep in 1-2-Zzz’ Program Enhancing the Journey to Achieve Better Sleep

Retrieved on: 
Tuesday, March 15, 2022
General Health, Pharmaceutical, Health, Sleep deprivation, Depression, Health, News, Weight gain, FDA, Caffeine, Ambi, Risk, Procter & Gamble, Sleep, Anxiety, Amnesia, Adult, Irritability, Overalls, Vicks, Sleep hygiene, Social media, Diphenhydramine, P&G, OH, Pharmaceutical industry

Just in time for National Sleep Week, ZzzQuil is on a mission to help people achieve Better Sleep in 1-2-Zzz.

Key Points: 
  • Just in time for National Sleep Week, ZzzQuil is on a mission to help people achieve Better Sleep in 1-2-Zzz.
  • ZzzQuil believes that a good nights sleep is key to a great morning and is here to help people achieve it, even as day-to-day demands increase.
  • Each week, we are sharing ways for people to implement healthy sleep hygiene improvements such as setting a consistent sleep schedule, developing a relaxing bedtime routine, or trying a sleep aid like ZzzQuil to achieve Better Sleep in 1-2-Zzz.
  • When you use a sleep aid like ZzzQuil, people can give their bodies the rest it needs for overall wellness*.

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

Retrieved on: 
Monday, January 31, 2022
NDS, Traffic barrier, Safety, Risk, Patient, Anaphylaxis, Therapy, Obiltoxaximab, Meningitis, Food, NASDAQ, Assistant, Infection, Headache, Office of the Assistant Secretary for Preparedness and Response, Cough, HHS, Anthrax, Human, Itch, Heat Biologics, Mab, Population, Death, Pharmacokinetics, Diphenhydramine, Hives, ASPR, Adult, Pre-medical, Bacillus anthracis, Hypersensitivity, Injection, Office of Inspector General, U.S. Department of Health and Human Services, Health Canada, GLOBE, Use, Acquisition, Pain, Time, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, IV, Nasal congestion, Vaccine, Pharmaceutical industry, Bacillus, Elusys Therapeutics, Heat

PARSIPPANY, N.J., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Elusys Therapeutics, Inc. (Elusys) announced today that it has finalized a contract with the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS) for the continued supply of ANTHIM (obiltoxaximab), an anthrax antitoxin, for use against a potential anthrax attack.

Key Points: 
  • If all options are exercised, the total contract value will be $80,864,000 with completion of the contract expected by the first half of 2023.
  • The acquisition is expected to close during the first quarter of 2022 and is subject to customary closing conditions.
  • Elusys, based in Parsippany, NJ, is focused on the development of antibody therapeutics for the treatment of infectious disease.
  • In July 2020, Health Canada approved ANTHIMs New Drug Submission (NDS) for the treatment of inhalation anthrax.

Washington Poison Center warns parents of continued dangers with the Benadryl™ Challenge

Retrieved on: 
Monday, November 23, 2020
Psychoactive drugs, Drugs, Receptor antagonists, Antiemetics, Hypnotics, Muscarinic antagonists, Sedatives, Antihistamines, Diphenhydramine, Benadryl, Cold medicine, Antihistamine

Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.

Key Points: 
  • Diphenhydramine is an antihistamine commonly found in over-the-counter sleep aids, cough and cold medications, and allergy medicationsmost notably the brand name Benadryl.
  • It is typically stored in an unsecured or unlocked cabinet, and bulk quantities are available for purchase.
  • WA Poison Center Cases of intentional self-harm or suicidal intent in adolescents ages 13-17 has increased 5% since 2019, and cases of abuse have increased 34%.
  • For questions or emergencies involving diphenhydramine or other potentially harmful substances, call the Washington Poison Center (1-800-222-1222).